General Information of DT
DT ID DTD0055
Gene Name ABCB9
Protein Name TAP-like protein
Gene ID
23457
UniProt ID
Q9NP78
TCDB ID
3.A.1.209.2
3D Structure

Modelled DT Structure

Method: homology modeling

Template PDB: 5U1D_B

Identity: 41.417%

Minimized Score: -1523.077 kcal/mol

Detail: Structure Info

Synonyms ABC transporter 9 protein; ABCB9; ATP-binding cassette sub-family B member 9; ATP-binding cassette transporter 9; EST122234; KIAA1520; TAPL; hABCB9
DT Family ATP-Binding Cassette (ABC) Superfamily
MHC Peptide Transporter (TAP) Family (ABCB)
Tissue Specificity Highly expressed in testis, and at moderatelevels in brain, spinal cord, and thyroid. Not expressed inmonocytes but strongly expressed during differentiation ofmonocytes to dendritic cells and macrophages.
Function This ATP-dependent low-affinity peptide transporter transporting a broad spectrum of peptides from the cytosol to the lysosomal lumen.
Endogenous Substrate(s) Peptides
Variability Data of This Drug Transporter (DT)

Regulatory Variability Data of This DT (VARIDT 3.0)

(β) Post-translational Modification of This DT

(γ) Transcriptional Regulation of This DT

(δ) Epigenetic Regulation of This DT

Structural Variability Data of This DT (VARIDT 2.0)

(β) Inter-species Structural Differences

General Variability Data of This DT (VARIDT 1.0)

(β) Disease-specific Protein Abundances of This DT

(γ) Species- and Tissue-specific DT Abundances

Molecular Transporting Profile of This DT

Full List of Drug(s) Transported by This DT

 Approved Drug

Click to Show/Hide the Full List of Drug:            2 Drugs in Total
Drug Name Highest Status Detail Indication ICD 11 Ref
Docetaxel
Approved Drug Info Lung cancer 2C25 [1]
Paclitaxel
Approved Drug Info Breast cancer 2C60-2C6Z [2]
References
1 RNA-sequencing dissects the transcriptome of polyploid cancer cells that are resistant to combined treatments of cisplatin with paclitaxel and docetaxel. Mol Biosyst. 2017 Sep 26;13(10):2125-2134.
2 Overexpression of microRNA-24 increases the sensitivity to paclitaxel in drug-resistant breast carcinoma cell lines via targeting ABCB9. Oncol Lett. 2016 Nov;12(5):3905-3911.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.